Recently, Li et al. reported that inhibition of STAT3 activity in breast cancer metastasis model simultaneously impaired matrix metalloproteinase (MMP)-2/9 and ROS generation and increased the CD8+ T cells in the TME [158]. The gene discussed is CD8A; the disease is breast carcinoma.